Neonatal administration of tamoxifen causes disruption of myometrial development but not adenomyosis in the C57/BL6J mouse

Reproduction

Volumn 139, Issue 6, 2010, Pages 1067-1075

  Mehasseb, Mohamed K ^a   Bell, S C ^a   Habiba, M A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DESMIN; ESTROGEN RECEPTOR ALPHA; FIBRONECTIN; LAMININ; TAMOXIFEN; VIMENTIN;

ADENOMYOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; MYOMETRIUM; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; UTERUS GROWTH;

ACTINS; ANIMALS; ANIMALS, NEWBORN; DESMIN; ENDOMETRIOSIS; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; FEMALE; FIBRONECTINS; IMMUNOHISTOCHEMISTRY; LAMININ; MICE; MICE, INBRED C57BL; MYOMETRIUM; TAMOXIFEN; VIMENTIN;

MUS;

EID: 77952603230     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-09-0443     Document Type: Article

References (39)

1. Batra S 1990 Interaction of antiestrogens with binding sites for muscarinic cholinergic drugs and calcium channel blockers in cell membranes. Cancer Chemotherapy and Pharmacology 26 310-312. (Pubitemid 20211121)
2. Bigsby RM, Aixin L, Luo K & Cunha GR 1990 Strain differences in the ontogeny of estrogen receptors in murine uterine epithelium. Endocrinology 126 2592-2596. (Pubitemid 20173052)
3. Bird CC, McElin TW & Manalo-Estrella P 1972 The elusive adenomyosis of the uterus - revisited. American Journal of Obstetrics and Gynecology 112 583-593.
4. Brody JR & Cunha GR 1989 Histologic, morphometric, and immunocyto-chemical analysis of myometrial development in rats and mice. I. Normal development. American Journal of Anatomy 186 1-20. (Pubitemid 19213506)
5. Cunha GR 1976 Stromal induction and specification of morphogenesis and cytodifferentiation of the epithelia of the mullerian ducts and urogenital sinus during development of the uterus and vagina in mice. Journal of Experimental Zoology 196 361-370.
6. Cunha GR, Battle E, Young P, Brody J, Donjacour A, Hayashi N & Kinbara H 1992 Role of epithelial-mesenchymal interactions in the differentiation and spatial organization of visceral smooth muscle. Epithelial Cell Biology 1 76-83.
7. Curtis KM, Hillis SD,Marchbanks PA & Peterson HB 2002 Disruption of the endometrial-myometrial border during pregnancy as a risk factor for adenomyosis. American Journal of Obstetrics and Gynecology 187 543-544.
8. Greaves P & White IN 2006 Experimental adenomyosis. Best Practice & Research. Clinical Obstetrics & Gynaecology 20 503-510.
9. Green AR, Styles JA, Parrott EL, Gray D, Edwards RE, Smith AG, Gant TW, Greaves P, Al-Azzawi F & White IN 2005 Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer. Experimental and Toxicologic Pathology 56 255-263. (Pubitemid 40312750)
10. Guttner J 1980 Adenomyosis in mice. Zeitschrift für Versuchstierkunde 22 249-251.
11. Horgan K, Cooke E, Hallet MB & Mansel RE 1986 Inhibition of protein kinase C mediated signal transduction by tamoxifen. Biochemical Pharmacology 35 4463-4465.
12. Huseby RA & Thurlow S 1982 Effects of prenatal exposure of mice to "low-dose" diethylstilbestrol and the development of adenomyosis associated with evidence of hyperprolactinemia. American Journal of Obstetrics and Gynecology 144 939-949. (Pubitemid 13216776)
13. Iguchi T & Sato T 2000 Endocrine disruption and developmental abnormalities of female reproduction. American Zoologist 40 402-411.
14. Irisawa S & Iguchi T 1990 Critical period of induction by tamoxifen of genital organ abnormalities in female mice. In Vivo 4 175-179.
15. Kostrzewska A, Laudanski T & Batra S 1997 Potent inhibition by tamoxifen of spontaneous and agonist-induced contractions of the human myometrium and intramyometrial arteries. American Journal of Obstetrics and Gynecology 176 381-386. (Pubitemid 27107927)
16. Kroeger EA & Brandes LJ 1985 Evidence tat tamoxifen is a histamine antagonist. Biochemical and Biophysical Research Communications 131 750-755.
17. Kurita T, Cooke PS & Cunha GR 2001 Epithelial-stromal tissue interaction in paramesonephric (Mullerian) epithelial differentiation. Developmental Biology 240 194-211. (Pubitemid 33143820)
18. Lam HY 1984 Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochemical and Biophysical Research Communications 118 27-32. (Pubitemid 14191943)
19. Levgur M, Abadi MA & Tucker A 2000 Adenomyosis: symptoms, histology, and pregnancy terminations. Obstetrics and Gynecology 95 688-691.
20. Li S 1994 Relationship between cellular DNA synthesis. PCNA expression and sex steroid hormone receptor status in the developing mouse ovary, uterus and oviduct. Histochemistry 102 405-413.
21. Lipton A & Morris ID 1986 Calcium antagonism by the antioestrogen tamoxifen. Cancer Chemotherapy and Pharmacology 18 17-20.
22. McCann TO & Myers RE 1970 Endometriosis in rhesus monkeys. American Journal of Obstetrics and Gynecology 106 516-523.
23. Mehasseb MK, Bell SC & Habiba MA 2009 The effects of tamoxifen and estradiol on myometrial differentiation and organization during early uterine development in the CD1 mouse. Reproduction 138 341-350.
24. Mori T & Nagasawa H 1983 Mechanisms of development of prolactin-induced adenomyosis in mice. Acta Anatomica 116 46-54. (Pubitemid 13115351)
25. Mori T, Nagasawa H & Nakajima Y 1982 Strain-difference in the induction of adenomyosis by intrauterine pituitary grafting in mice. Laboratory Animal Science 32 40-41. (Pubitemid 12105498)
26. Mori T, Ohta Y & Nagasawa H 1984 Ultrastructural changes in uterine myometrium of mice with experimentally-induced adenomyosis. Experientia 40 1385-1387. (Pubitemid 15179227)
27. Mori T, Singtripop T & Kawashima S 1991 Animal model of uterine adenomyosis: is prolactin a potent inducer of adenomyosis in mice? American Journal of Obstetrics and Gynecology 165 232-234.
28. Mori T, Nakahashi K, Kyokuwa M, Yamasaki S & Nagasawa H 2002 A matrix metalloproteinase inhibitor, ONO-4817, retards the development of mammary tumor and the progression of uterine adenomyosis in mice. Anticancer Research 22 3985-3988. (Pubitemid 36134423)
29. Nagasawa H & Kusakawa S 2001 Relationship between incidence and onset age of mammary tumours and uterine adenomyosis in four strains of mice: comparison with the findings of 40 generations previously. In Vivo 15 345-349. (Pubitemid 33039992)
30. Nagasawa H, Konishi R, Naito T, Ohmiya S & Mori T 1987 Relationship between mammary tumourigenesis and uterine adenomyosis in four strains of mice. In Vivo 1 237-240. (Pubitemid 17163354)
31. Nagasawa H, Aoki M, Mori T, Yamamoto K, Inaba T & Mori J 1989 Stimulation of mammary tumourigenesis and inhibition of uterine adenomyosis by suppressed progesterone effects in SHN mice. Anticancer Research 9 827-832. (Pubitemid 19266313)
32. Ohta Y, Mori T & Nagasawa H 1985 Ultrastructural changes of endometrium and myometrium during development of adenomyosis in mice with ectopic pituitary transplants. Zoological Science 2 239-247.
33. Ostrander PL, Mills KT & Bern HA 1985 Long-term responses of the mouse uterus to neonatal diethylstilbestrol treatment and to later sex hormone exposure. Journal of the National Cancer Institute 74 121-135.
34. Parrott E, Butterworth M, Green A, White IN & Greaves P 2001 Adenomyosis - a result of disordered stromal differentiation. American Journal of Pathology 159 623-630. (Pubitemid 32751092)
35. Romberger DJ 1997 Fibronectin. International Journal of Biochemistry and Cell Biology 29 939-943.
36. Sasaki T, Fassler R & Hohenester E 2004 Laminin: the crux of basement membranes assembly. Journal of Cell Biology 164 959-963. (Pubitemid 38429121)
37. Sato T, Okamura H, Ohta Y, Hayashi S, Takasugi N & Iguchi T 1992 Estrogen receptor expressin in genital tract of female mice treated neonatally with diethylstilbestrol. In Vivo 6 151-156.
38. Suire RA, Goodman DG, Valerio MG, Fredrickson TN, Strandberg JD, Levitt MH, Lingeman CH, Harshbarger JC & Dawe CJ 1978 Female reproductive system. In Pathology of Laboratory Animals, vol 2, pp 1051-1262. Eds K Benirschke, FM Garner & TC Jones. New York: Springer-Verlag.
39. Yamashita S, Newbold RR, McLachlan JA & Korach KS 1989 Developmental pattern of estrogen receptor expression in female mouse genital tracts. Endocrinology 125 2888-2896. (Pubitemid 20010662)